Litracen

This classification denotes an antidepressant agent with the molecular formula C20H23N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2B3D399IVR, chemically known as 9-(3-methylaminopropylidene)-10,10-dimethyl-9,10-dihydroanthracene. but generally known as litracen, which bears US NIH Compound Identifier 82730. European Medicines Agency schedules Litracen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08537MIG. The term LITRACEN is an International Non-Proprietary Name. LITRACEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule litracen under HS 29214980 and SITC 51454. As of Q4 2014, LITRACEN remains the US FDA Preferred Term for this commodity. Litracen bears US NLM identifiers UMLS ID C1881414 and NCI Concept Code C66022. SMILES: N(CC/C=C1/c2c(C(c3c1cccc3)(C)C)cccc2)C.